Editing-independent effects of Drosophila Adar on heterochromatin silencing
- Khadija Hajji1,
- Damiano Amoruso1,
- Barbora Novakova1,
- Nagraj Sambrani1,
- Deying Yang1,
- Anzer Khan1,
- Vojtech Bystry1,
- Alejandro Medaglia-Mata1,
- Domenico Alessandro Silvestris2,
- Ernesto Picardi2,
- Mary A. O'Connell1 and
- Liam Peter Keegan1,3
- 1 CEITEC Masaryk University, Kamenice 735/5, E35, Brno, 62500, Czech Republic.;
- 2 Department of Biosciences, Biotechnology and Environment, University of Bari "Aldo Moro", Via Orabona 4, Bari, 70124, Italy.
- ↵* Corresponding author; email: liam.keegan{at}ceitec.muni.cz
Abstract
ADAR RNA editing enzymes deaminate selected adenosines to inosines in dsRNA. In Drosophila, inosine in dsRNA inhibits cleavage by Dcr2 and some ADAR proteins contribute an additional, editing-independent inhibition. The Drosophila AdarG isoform, in particular, has been proposed to inhibit HP1-mediated heterochromatin silencing of repetitive sequences initiated by specific dsRNAs. To address the functions of AdarG, we overexpressed it from new UAS-Adar lines, under the control of a temperature-regulated Act5Cts-GAL4 driver. Overexpression of the adult AdarG isoform or catalytically inactive AdarE374A led to larval lethality with some escaper pupae that show an ecdysone-related, head eversion defect. This indicates an editing-independent effect of high Adar expression. Pupae show aberrantly elevated innate immune and early ecdysone gene transcript expression and no flies eclose. RNAi knockdown of Ecdysone Receptor A (EcRA) or increased expression of the histone H3K9me2,3-associated HP1 protein partially rescue AdarG overexpression defects and normalize gene expression in rescued progeny flies. In other reports, Drosophila mutants with reduced HP1, or egg (SetDB1), Su(var)3-9 double mutants with reduced histone H3K9me2,3 also produce larvae with ecdysone-related and innate immune defects. We show that overexpressed AdarG inhibits histone H3K9me-mediated epigenetic silencing through an editing-independent effect, most likely at the dsRNA/Dcr2/Ago2 initiation stage.
Keywords
- Received November 21, 2025.
- Accepted February 17, 2026.
- Published by Cold Spring Harbor Laboratory Press for the RNA Society
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml). After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.










